AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 94 filers reported holding AVROBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504,989 | +85.9% | 327,915 | +14.7% | 0.00% | 0.0% |
| Q2 2023 | $271,597 | -18.4% | 285,861 | -14.2% | 0.00% | 0.0% |
| Q1 2023 | $332,998 | +47.0% | 332,998 | +4.8% | 0.00% | 0.0% |
| Q4 2022 | $226,596 | -10.1% | 317,851 | -19.0% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | -42.2% | 392,624 | -17.1% | 0.00% | 0.0% |
| Q2 2022 | $436,000 | -50.9% | 473,644 | -29.6% | 0.00% | -66.7% |
| Q1 2022 | $888,000 | -51.1% | 672,433 | +42.5% | 0.00% | -25.0% |
| Q4 2021 | $1,817,000 | -0.5% | 471,934 | +44.2% | 0.00% | 0.0% |
| Q3 2021 | $1,826,000 | +69.1% | 327,248 | +169.5% | 0.00% | +100.0% |
| Q2 2021 | $1,080,000 | -29.0% | 121,448 | +1.3% | 0.00% | -50.0% |
| Q1 2021 | $1,521,000 | +16.8% | 119,871 | +28.4% | 0.00% | 0.0% |
| Q4 2020 | $1,302,000 | +670.4% | 93,380 | +621.5% | 0.00% | +300.0% |
| Q3 2020 | $169,000 | -85.3% | 12,942 | -80.4% | 0.00% | -83.3% |
| Q2 2020 | $1,149,000 | +52.2% | 65,863 | +75.6% | 0.01% | +200.0% |
| Q4 2019 | $755,000 | – | 37,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |